HNMPA- (AM) 3
CAS: 120944-03-8
Ref. 3D-FH171943
| 1mg | Descontinuado | ||
| 2mg | Descontinuado | ||
| 5mg | Descontinuado | ||
| 10mg | Descontinuado | ||
| 25mg | Descontinuado |
Informação sobre produto
Nome:
HNMPA- (AM) 3
Descrição:
HNMPA-(AM) 3 is a potent inhibitor of tumor cell proliferation and an insulin sensitizing agent. It has been shown to inhibit the uptake of glucose by cancer cells, which may be due to its effect on insulin resistance. HNMPA- (AM) 3 also alters the signaling pathways in cancer cells, which leads to inhibition of tumor cell growth. This drug has been shown to prevent the differentiation of ventricular myocytes in culture and to reduce their viability by inhibiting protein synthesis and fatty acid metabolism. HNMPA- (AM) 3 also inhibits the cation channel that is present in L6 cells, leading to decreased cellular excitability. The effects of this drug are not limited to cancer cells as it can also affect other cell types such as PC12 cells.
Aviso:
Os nossos productos estão destinados exclusivamente para uso em laboratório. Para qualquer outra aplicação, por favor entre em contacto.
Marca:
Biosynth
Armazenamento a longo prazo:
Notas:
Propriedades químicas
Peso molecular:
454.36 g/mol
Fórmula:
C20H23O10P
Pureza:
Min. 95%
InChI:
InChI=1S/C20H23O10P/c1-14(21)25-11-28-20(19-9-8-17-6-4-5-7-18(17)10-19)31(24,29-12-26-15(2)22)30-13-27-16(3)23/h4-10,20H,11-13H2,1-3H3
Chave InChI:
InChIKey=UQODAZKXEREJLZ-UHFFFAOYSA-N
SMILES:
CC(=O)OCOC(c1ccc2ccccc2c1)P(=O)(OCOC(C)=O)OCOC(C)=O
MDL:
Ponto de fusão:
Ponto de ebulição:
Ponto de inflamação:
Densidade:
Concentração:
EINECS:
Merck:
Código HS:
